Amin, Elianna M

WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. [electronic resource] - Cancer cell Dec 2011 - 768-80 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1878-3686

10.1016/j.ccr.2011.10.016 doi


Animals
Cell Line, Tumor
Cell Nucleus--metabolism
Choroidal Neovascularization--genetics
Denys-Drash Syndrome--genetics
Gene Expression
Gene Expression Regulation, Neoplastic
Genes, Reporter
Humans
Luciferases, Renilla--biosynthesis
Mice
Mice, Inbred C57BL
Mice, Nude
Neoplasm Transplantation
Neoplasms--blood supply
Neovascularization, Pathologic--genetics
Nuclear Proteins--metabolism
Podocytes--metabolism
Promoter Regions, Genetic
Protein Binding
Protein Isoforms--genetics
Protein Kinase Inhibitors--pharmacology
Protein Serine-Threonine Kinases--antagonists & inhibitors
Protein Transport
RNA Interference
RNA Splicing--genetics
RNA-Binding Proteins--metabolism
Serine-Arginine Splicing Factors
Vascular Endothelial Growth Factor B--genetics
Vascular Endothelial Growth Factor Receptor-2--metabolism
WT1 Proteins--genetics